Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Gynecologic Oncology

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ygyno.2012.07.098PMID 22828962PMCID PMC3472044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies

  2011cited by this paper
• Targeting regulatory T cells in cancer.

  2011cited by this paper
• Regulation and functions of the IL-10 family of cytokines in inflammation and disease.

  2011cited by this paper
• Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation

  2011cited by this paper
• Indoleamine 2,3-dioxygenase, Tregs and cancer.

  2011cited by this paper
• Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models

  2011cited by this paper
• Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer.

  2011cited by this paper
• Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

  2011cited by this paper
• Imatinib potentiates anti-tumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

  2011cited by this paper
• Sensing the outside world: TSLP regulates barrier immunity

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

  2010cited by this paper
• Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression

  2010cited by this paper
• Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responses.

  2010cited by this paper
• CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

  2010cited by this paper
• Papillomaviruses in the causation of human cancers - a brief historical account.

  2009cited by this paper
• Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.

  2009cited by this paper
• Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function

  2009cited by this paper
• Evolving immunosuppressive microenvironment during human cervical carcinogenesis

  2008cited by this paper
• Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix.

  2008cited by this paper
• Expression of indoleamine 2, 3‐dioxygenase and the recruitment of Foxp3‐expressing regulatory T cells in the development and progression of uterine cervical cancer

  2007cited by this paper
• Vaccines to treat cancer‐an old approach whose time has arrived

  2007cited by this paper
• Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

  2007cited by this paper
• Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients

  2006cited by this paper
• De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.

  2005cited by this paper
• TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand

  2005cited by this paper
• Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.

  2005cited by this paper
• Immunosuppressive networks in the tumour environment and their therapeutic relevance

  2005cited by this paper
• Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells.

  2005cited by this paper
• Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.

  2004cited by this paper
• Functional regulation of human neutrophil Fc γ receptors

  2004cited by this paper
• Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents.

  2004cited by this paper
• Functional regulation of human neutrophil Fc gamma receptors.

  2004cited by this paper
• Inducing Tumor Immunity through the Selective Engagement of Activating Fcγ Receptors on Dendritic Cells

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Syndecan-1 in B lymphoid malignancies

  2002cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• IgG Fc receptors.

  2001cited by this paper
• Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study.

  2001cited by this paper
• Antibodies against Human Papillomavirus Type 16 and 18 E6 and E7 Proteins in Cervicovaginal Washings and Serum of Patients with Cervical Neoplasia

  2001cited by this paper
• Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer1

  2001cited by this paper
• Progress in human tumour immunology and immunotherapy

  2001cited by this paper
• Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical‐carcinoma patients from Russia

  2000cited by this paper
• Advances in the diagnosis and treatment of human papillomavirus infections.

  1999cited by this paper
• Viruses in human cancers.

  1999cited by this paper
• Screening for cervical cancer.

  1998cited by this paper
• Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

  1997cited by this paper
• Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumors

  1995cited by this paper
• A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

  1995cited by this paper
• Tumor antigens recognized by T lymphocytes.

  1994cited by this paper
• Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.

  1994cited by this paper
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

  1993cited by this paper
• Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16.

  1992cited by this paper
• Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

  1991cited by this paper
• Viruses in human cancers

  1991cited by this paper
• Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic.

  1989cited by this paper
• Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

  1974cited by this paper
• Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

  1972cited by this paper
• The Immune Reaction as a Stimulator of Tumor Growth

  1972cited by this paper
• Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

  1971cited by this paper
• Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.

  1969cited by this paper
• Effect on Tumour Growth in Syngeneic Recipients of Antibodies Against Tumour-Specific Antigens in Methylcholanthrene-Induced Mouse Sarcomas

  1964cited by this paper
• STUDIES ON SPECIFIC TRANSPLANTATION RESISTANCE TO POLYOMA-VIRUS-INDUCED TUMORS. IV. STABILITY OF THE POLYOMA CELL ANTIGEN.

  1964cited by this paper

• Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis

  2025cites this paper
• Comprehensive analysis of zinc finger protein 367 as a potential pan-cancer diagnostic and prognostic biomarker and underlying biological mechanisms

  2025cites this paper
• Evaluating the relationship between human papilloma virus infections, prostate cancer and interleukin-12 levels

  2025cites this paper
• Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments

  2025cites this paper
• Development of therapeutic cancer vaccines based on cancer immunity cycle

  2025cites this paper
• Multi-omics analysis identifies DLX4 as a novel biomarker for diagnosis, prognosis, and immune infiltration: from pan-cancer to renal cancer

  2025cites this paper
• Transcriptomic profiling reveals mechanism, therapeutic potential, and prognostic value of cancer stemness characteristic in nasopharyngeal carcinoma

  2025influential citation
• TM4SF19—A New Biomarker for Diagnosis and Prognosis of Bladder Urothelial Carcinoma

  2024cites this paper
• Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes

  2024cites this paper
• MERS-CoV Infection and Its Impact on the Expression of TSLP Cytokine and IgG Antibodies: An In Vivo and In Vitro Study

  2024cites this paper
• GRB7 Plays a Vital Role in Promoting the Progression and Mediating Immune Evasion of Ovarian Cancer

  2024cites this paper
• IL-37 attenuated HPV induced inflammation and growth of oral epithelial cells via regulating autophagy

  2024cites this paper
• Investigating immune and non‐immune cellular profiles in recurrent respiratory papillomatosis by multi‐omics

  2024cites this paper
• Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer

  2023cites this paper
• Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression

  2023cites this paper
• The Relationship between Furin and Chronic Inflammation in the Progression of Cervical Intraepithelial Neoplasia to Cancer: A Cross-Sectional Study

  2023cites this paper
• The role of CD4+ T cells in tumor and chronic viral immune responses

  2023cites this paper
• Design and evaluation of α-helix-based peptide inhibitors for blocking PD-1/PD-L1 interaction.

  2023cites this paper
• Pan‐cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers

  2023cites this paper
• High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle

  2023cites this paper
• Role of thymic stromal lymphopoietin in allergy and beyond

  2022cites this paper
• Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer

  2022cites this paper
• Development of an inhaled anti-TSLP therapy for asthma.

  2022cites this paper
• CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma

  2022cites this paper
• The Prognostic Significance and Potential Mechanism of Prolyl 3-Hydroxylase 1 in Hepatocellular Carcinoma

  2022cites this paper
• High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma

  2022cites this paper
• Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies

  2022cites this paper
• High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma

  2022cites this paper
• Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets

  2022cites this paper
• Importance of the Immune Microenvironment in the Spontaneous Regression of Cervical Squamous Intraepithelial Lesions (cSIL) and Implications for Immunotherapy

  2022cites this paper
• The immune landscape during the tumorigenesis of cervical cancer

  2021cites this paper
• Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer

  2021cites this paper
• High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling

  2021cites this paper
• Contribution of the Microbiota and their Secretory Products to Inflammation and Colorectal Cancer Pathogenesis: The Role of Toll-like Receptors.

  2021cites this paper
• Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment

  2021cites this paper
• Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer

  2021cites this paper
• Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study

  2021cites this paper
• Physical Activity of ≥7.5 MET-h/Week Is Significantly Associated with a Decreased Risk of Cervical Neoplasia

  2020cites this paper
• Whole-Course Application of Dexmedetomidine Combined with Ketorolac in Nonnarcotic Postoperative Analgesia for Patients with Lung Cancer Undergoing Thoracoscopic Surgery: A Randomized Control Trial.

  2020cites this paper
• Impact of Helminth Infections on Female Reproductive Health and Associated Diseases

  2020cites this paper
• Role of Platelets, Bacterial Vaginosis, Serum Interleukinsand TNF In Genital Human Papillomavirus InfectionAmong Black Female Population in Nigeria

  2020cites this paper
• Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A2B adenosine receptor, resulting in protection against the activity of cytotoxic T cells.

  2020cites this paper
• From the Hellstrom paradox toward cancer cure.

  2019cites this paper
• Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis

  2019cites this paper
• An In Vitro and In Vivo Evaluation of the Anticancer Potential of Resveratrol and Pterostilbene Against HPV-E6 Positive Cancers

  2019cites this paper
• HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1

  2019cites this paper
• Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review

  2019cites this paper
• Tumor Regression and Cure Depends on Sustained Th1 Responses

  2018cites this paper
• Interferon epsilon mRNA expression could represent a potential molecular marker in cervical cancer.

  2018cites this paper
• Immune modulation of a lipid-soluble extract of Pinellia pedatisecta Schott in the tumor microenvironment of an HPV+ tumor-burdened mouse model.

  2018cites this paper
• T-Helper 1 Immune Response in Metastatic Lymph Nodes of Pancreatic Ductal Adenocarcinoma: A Marker For Prolonged Survival

  2018cites this paper
• Polymorphism of IFN-γ +874T/A associated with production of IFN-γ affects human papillomavirus susceptibility in rural women from Luohe, Henan, China

  2018cites this paper
• A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol

  2018cites this paper
• Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes

  2018cites this paper
• Analysis of middle- and long-term efficacy of thoracoscope-assisted segmental resection of the lung on non-small cell lung cancer in the early stage

  2018cites this paper
• Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions

  2017cites this paper
• Effects of different methods of anesthesia and analgesia on immune function and serum tumor marker levels in critically ill patients

  2017cites this paper
• Normalization of regulatory T cells, serum TGF-β1, and LTN after 5-aminolevulinic acid-photodynamic therapy in patients with condyloma acuminate

  2017cites this paper
• A perspective on the challenges and issues in developing biomarkers for human allergic risk assessments.

  2017cites this paper
• Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor response

  2017cites this paper
• The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression

  2017cites this paper
• Effects of different anesthesia methods on postoperative transient neurological syndrome in patients with lumbar disc herniation

  2017cites this paper
• In situ FoxP 3 + and IL-10 over-expression is associated with high grade anal lesions in HIV infected patients

  2016influential citation
• Model systems of human papillomavirus‐associated disease

  2016cites this paper
• In vivo Antitumor Effect of an HPV-specific Promoter driving IL-12 Expression in an HPV 16-positive Murine Model of Cervical Cancer

  2016cites this paper
• An In Vitro Model That Predicts the Therapeutic Efficacy of Immunomodulatory Antibodies

  2016cites this paper
• Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A/p16 mRNA: a combined strategy to cervical cancer diagnosis

  2016cites this paper
• Ligand–receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma

  2016cites this paper
• Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study

  2016cites this paper
• Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer

  2016cites this paper
• Mechanisms of 2,4-Dinitrochlorobenzene-induced acute inflammation in Human Papillomavirus type 16 E7 oncoprotein expressing skin

  2015cites this paper
• Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer

  2015cites this paper
• Association between the human papillomavirus, bacterial vaginosis and cervicitis and the detection of abnormalities in cervical smears from teenage girls and young women

  2015cites this paper
• Association between interluekin-17 gene polymorphisms and the risk of cervical cancer in a Chinese population.

  2015cites this paper
• Atopic Dermatitis Is Associated With Cervical High Risk Human Papillomavirus Infection

  2015cites this paper
• TSLP Expression and High Serum TSLP Level Indicate a Poor Prognosis in Gastric Cancer Patients

  2015cites this paper
• IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes

  2015cites this paper
• FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma

  2015cites this paper
• The role of inflammation in cervical cancer.

  2014cites this paper
• Role of cytokines in genesis, progression and prognosis of cervical cancer.

  2014cites this paper
• Mediation by peer violence victimization of sexual orientation disparities in cancer-related tobacco, alcohol, and sexual risk behaviors: pooled youth risk behavior surveys.

  2014cites this paper
• Immunosuppression in cervical cancer with special reference to arginase activity.

  2014cites this paper
• HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models

  2014cites this paper
• [Breast and cervical cancer in patients with systemic lupus erythematosus].

  2014cites this paper
• Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions

  2014cites this paper
• Curing Mice with Large Tumors by Locally Delivering Combinations of Immunomodulatory Antibodies

  2014cites this paper
• Immune therapy for human papillomaviruses-related cancers.

  2014cites this paper
• HPV16-E7 Expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions

  2014cites this paper
• Anti-HE4 antibodies in infertile women and women with ovarian cancer.

  2013cites this paper
• Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.

  2013cites this paper
• p-regulation of pro-angiogenic factors and establishment of olerance in malignant pleural effusions lizabeth

  2013cites this paper
• The Association of the Immune Response Genes to Human Papillomavirus-Related Cervical Disease in a Brazilian Population

  2013cites this paper
• Combinatorial PD-1 Blockade and CD137 Activation Has Therapeutic Efficacy in Murine Cancer Models and Synergizes with Cisplatin

  2013cites this paper
• Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovir

  2013cites this paper
• Long-lasting Complete Regression of Established Mouse Tumors by Counteracting Th2 Inflammation

  2013cites this paper
• Monoclonal antibodies against human papillomavirus E7 oncoprotein for diagnosis of cervical neoplasia and cancer

  2012cites this paper